Samuel George A. III (CIK 1878732) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-13). Recent activity: Buy LCTX (6,075 shares), Sell LCTX (2,502 shares), Buy LCTX (1,735 shares), Sell LCTX (65 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-13 | Lineage Cell Therapeutics, Inc. (LCTX) | General Counsel and Secretary | Buy | 6,075 | $0 |
| 2026-02-13 | Lineage Cell Therapeutics, Inc. (LCTX) | General Counsel and Secretary | Sell | 2,502 | $4,504 |
| 2025-12-19 | Lineage Cell Therapeutics, Inc. (LCTX) | General Counsel and Secretary | Buy | 1,735 | $0 |
| 2025-12-19 | Lineage Cell Therapeutics, Inc. (LCTX) | General Counsel and Secretary | Sell | 65 | $109 |
Source: SEC Form 4 filings · as of 2026-02-13